Maxwell V. Meng, MD


Associate Professor, Department of Urology, UCSF

Phone: (415) 353-7171 (appts)
Box 1711, UCSF
San Francisco, CA 94143-1711

View on UCSF Profiles

Additional Websites


A, 1991, Biochemical Sciences, Harvard College, Cambridge, MA
MD, 1995, Medicine, Johns Hopkins School of Medicine, Baltimore, MD
General surgery & urology, UCSF, 1995-2001
Laparoscopic fellowship, UCSF, 2001-2002
Oncology fellowship, UCSF, 2002-2003

Professional Experience

  • 2001-2003
    Clinical Instructor, Dept. of Urology, UCSF
  • 2001-present
    Attending Surgeon, San Francisco Veterans Hospital
  • 2001-present
    Attending Surgeon, San Francisco General Hospital
  • 2003-2007
    Assistant Professor in Residence, Dept. of Urology, UCSF
  • 2007-present
    Associate Professor in Residence, Dept. of Urology, UCSF

Honors & Awards

  • 1987
    Westinghouse Science Talent Search, 7th Place
  • 1991
    Magna cum laude, Harvard College
  • 1995
    Alpha Omega Alpha, Johns Hopkins
  • 1999
    Third Prize, Northern California Urology Residents Seminar
  • 1999
    Pfizer Scholar in Urology
  • 2001
    Joseph F. McCarthy Essay Contest, 3rd Place, Western Section AUA
  • 2002
    Prostate Cancer Research Fellow
  • 2004
    William R. Smart Distinguished Teaching Award (selected by residents)
  • 2005
    Excellence in Direct Teaching, Academy of Medical Educators, UCSF
  • 2006
    Ambrose/Reed Socioeconomic Prize Essay (AUA)
  • 2006
    AUA leadership Program (1 of 16 selected nationally biennially)
  • 2006
    Miley B. Wesson Essay Contest, 2nd Place, AUA

Selected Publications

  1. Meng MV. Editorial comment for zargar et Al. J Endourol. 2015 Jan; 29(1):102.
    View on PubMed
  2. Meng MV, Boughey JC. Treating metastatic prostate cancer now and in the future. Bull Am Coll Surg. 2014 Sep; 99(9):55-7.
    View on PubMed
  3. Hampson LA, Brajtbord JS, Meng MV. The future of quality in urologic oncology: evaluating the horizon of surgical standards. Urol Oncol. 2014 Aug; 32(6):735-40.
    View on PubMed
  4. Meng M. Commentary on "Single nucleotide polymorphisms and risk of recurrence of renal-cell carcinoma: a cohort study." Schutz FA, Pomerantz MM, Gray KP, Atkins MB, Rosenberg JE, Hirsch MS, McDermott DF, Lampron ME, Lee GS, Signoretti S, Kantoff PW, Freedman ML, Choueiri TK, Dana-Farber Cancer Institute, Boston, MA 02115.: Lancet Oncol 2013;14(1):81-87. [Epub 2012 Dec 7]. doi: 10.1016/S1470-2045(12)70517-X. Erratum in, Lancet Oncol 2013;14(3):e89. Urol Oncol. 2014 May; 32(4):512-3.
    View on PubMed
  5. Hsieh MH, Meng MV. Prostate Cancer Screening and Risk of Litigation: Caught between Scylla and Charybdis. J Urol. 2014 Jun; 191(6):1648-9.
    View on PubMed
  6. Morgan TM, Meng MV, Cooperberg MR, Cowan JE, Weinberg V, Carroll PR, Lin DW. A risk-adjusted definition of biochemical recurrence after radical prostatectomy. Prostate Cancer Prostatic Dis. 2014 Jun; 17(2):174-9.
    View on PubMed
  7. Garcia MM, Gottschalk AR, Brajtbord J, Konety BR, Meng MV, Roach M, Carroll PR. Endoscopic gold fiducial marker placement into the bladder wall to optimize radiotherapy targeting for bladder-preserving management of muscle-invasive bladder cancer: feasibility and initial outcomes. PLoS One. 2014; 9(3):e89754.
    View on PubMed
  8. Meng M, Gao X, Han LJ, Li XY, Wu D, Li HZ, Chen QJ. Correlation analysis between starch properties and single nucleotide polymorphisms of waxy genes in common rye (Secale cereale L.). Genet Mol Res. 2014; 13(2):2574-89.
    View on PubMed
  9. Whitson JM, Meng M. Extent of lymphadenectomy does not improve the survival of patients with renal cell carcinoma and nodal metastases: biases associated with the handling of missing data. BJU Int. 2014 Jan; 113(1):2-3.
    View on PubMed
  10. Friedman GD, Schwalbe J, Achacoso N, Meng MV, Kroenke CH, Habel LA. Antidepressants and testicular cancer. Cancer Causes Control. 2014 Feb; 25(2):251-8.
    View on PubMed
  11. Benner C, Greenberg M, Shepard N, Meng MV, Rabow MW. The natural history of symptoms and distress in patients and families following cystectomy for treatment of muscle invasive bladder cancer. J Urol. 2014 Apr; 191(4):937-42.
    View on PubMed
  12. Cary KC, Cowan JE, Sanford M, Shinohara K, Perez N, Chan JM, Meng MV, Carroll PR. Predictors of pathologic progression on biopsy among men on active surveillance for localized prostate cancer: the value of the pattern of surveillance biopsies. Eur Urol. 2014 Aug; 66(2):337-42.
    View on PubMed
  13. Meng MV. Editorial comment. Urology. 2013 Sep; 82(3):545-6.
    View on PubMed
  14. Meng MV, Nelson H. What is the appropriate extent of lymphadenectomy for bladder cancer? Bull Am Coll Surg. 2013 Jul; 98(7):60-2.
    View on PubMed
  15. Odisho AY, Washington SL, Meng MV, Cowan JE, Simko JP, Carroll PR. Benign prostate glandular tissue at radical prostatectomy surgical margins. Urology. 2013 Jul; 82(1):154-9.
    View on PubMed
  16. Punnen S, Meng MV, Cooperberg MR, Greene KL, Cowan JE, Carroll PR. How does robot-assisted radical prostatectomy (RARP) compare with open surgery in men with high-risk prostate cancer? BJU Int. 2013 Aug; 112(4):E314-20.
    View on PubMed
  17. Fung-Kee-Fung SD, Porten SP, Meng MV, Kuettel M. The role of active surveillance in the management of prostate cancer. J Natl Compr Canc Netw. 2013 Feb 1; 11(2):183-7.
    View on PubMed
  18. Meng MV. Commentary on "Laparoendoscopic single-site (LESS) partial nephrectomy short-term outcomes." Rais-Bahrami S, George AK, Montag S, Okhunov Z, Richstone L, The Arthur Smith Institute for Urology, Hofstra North Shore-LIJ School of Medicine, New Hyde Park, NY: BJU Int 2012 (Epub ahead of print). Urol Oncol. 2013 Jan; 31(1):131-2.
    View on PubMed
  19. Meng MV. Commentary on "Radiofrequency ablation of incidental benign small renal mass: outcomes and follow-up protocol." Tan YK, Best SL, Olweny E, Park S, Trimmer C, Cadeddu JA, Department of Urology, University of Texas Southwestern Medical School, Dallas, Texas, TX. Urol Oncol. 2013 Jan; 31(1):132-3.
    View on PubMed
  20. Meng MV. Commentary on "Predicting the histology of small renal masses using preoperative dynamic contrast-enhanced magnetic resonance imaging." Kim JH, Bae JH, Lee KW, Kim ME, Park SJ, Park JY, Department of Urology, Soonchunhyang University Hospital, Seoul, Korea. Urol Oncol. 2013 Jan; 31(1):133-4.
    View on PubMed

Go to UCSF Profiles, powered by CTSI